http://www.oncternal.com
Oncternal Therapeutics, Inc. Company Intro
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Industry
Healthcare
Oncternal Therapeutics, Inc. Headquaters
12230 El Camino Real
San Diego,92130
United States
Oncternal Therapeutics, Inc. Share price
14 Dec 2021 18:04 GMT
$2.5400
-0.02 (-0.78 %)
Oncternal Therapeutics, Inc. Market cap
$126.877 M
WMC RANKING
2022
Oncternal Therapeutics, Inc. # 239
BiotechnologyLatest Oncternal Therapeutics, Inc. News
06 Jan 2022
23 Stocks Moving in Thursday's Pre-Market Session - Benzinga
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday.
06 Jan 2022
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Receives Consensus Rating of "Buy" from Brokerages
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has been given a consensus recommendation of "Buy" by the six brokerages that are covering the company,...
06 Jan 2022
EDELWEISS 3 Trial Positive Topline Results: ObsEva S.A. (OBSV) stock Hikes Premarket
ObsEva S.A. (OBSV) stock became bullish premarket on the news of its positive topline data from its Phase 3 trial of Linzagolix.
WMC Market Score
WMC Market to Revenue Score
Oncternal Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Oncternal Therapeutics, Inc. | USD | $3,545 | $22,295 | $-18,435 | $1,269M | 239 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $713,370B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $539,620B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,540B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Oncternal Therapeutics, Inc. | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
